- Phare
- Validé par KD/KO
Anticorps Polyclonal de lapin anti-c-MYC
c-MYC Polyclonal Antibody for FC (Intra), IF
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain, souris
Applications
IF, FC (Intra)
Conjugaison
CoraLite®555 Fluorescent Dye
N° de cat : CL555-10828
Synonymes
Galerie de données de validation
Applications testées
Résultats positifs en IF | cellules HEK-293, |
Résultats positifs en cytométrie | cellules Raji |
Dilution recommandée
Application | Dilution |
---|---|
Immunofluorescence (IF) | IF : 1:50-1:500 |
Flow Cytometry (FC) | FC : 0.20 ug per 10^6 cells in a 100 µl suspension |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Informations sur le produit
CL555-10828 cible c-MYC dans les applications de IF, FC (Intra) et montre une réactivité avec des échantillons Humain, souris
Réactivité | Humain, souris |
Hôte / Isotype | Lapin / IgG |
Clonalité | Polyclonal |
Type | Anticorps |
Immunogène | c-MYC Protéine recombinante Ag1263 |
Nom complet | v-myc myelocytomatosis viral oncogene homolog (avian) |
Masse moléculaire calculée | 49 kDa |
Poids moléculaire observé | 62-65 kDa, 50 kDa |
Numéro d’acquisition GenBank | BC000141 |
Symbole du gène | MYC |
Identification du gène (NCBI) | 4609 |
Conjugaison | CoraLite®555 Fluorescent Dye |
Excitation/Emission maxima wavelengths | 557 nm / 570nm |
Forme | Liquide |
Méthode de purification | Purification par affinité contre l'antigène |
Tampon de stockage | PBS avec glycérol à 50 %, Proclin300 à 0,05 % et BSA à 0,5 %, pH 7,3. |
Conditions de stockage | Stocker à -20 °C. Éviter toute exposition à la lumière. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
Function
c-Myc (also known as Myc), together with l-Myc and n-Myc, belongs to the Myc family of transcription factors. c-Myc has a basic helix-loop-helix leucine zipper domain and through heterodimerization can bind and regulate the transcriptional activity of genes, either by repression or activation. It is a key player in the regulation of cell growth and cell cycle progression and acts as a proto-oncogene.
Tissue specificity
c-Myc is ubiquitously expressed in almost all cell types and its expression positively correlates with tissue proliferative capacity. c-Myc is also expressed during embryogenesis and is upregulated in many cancer types.
Involvement in disease
· Upregulated in many cancer types, especially in aggressive, poorly differentiated tumors.
· Mutations in the MYC gene and breakpoint translocations within the MYC gene cause Burkitt lymphoma.
Isoforms
There are 3 different isoforms of c-Myc: c-Myc1, c-Myc2, and c-MycS (PMID: 16260605). They differ in molecular size, can be preferentially expressed during cell growth, and are reported to be functionally distinct.
Post-translational modifications
c-Myc is subject to various post-translational modifications, including phosphorylation, acetylation, and ubiquitinylation (PMID: 16987807), which regulate its activity.
Cellular localization
c-Myc localizes to the nucleus but can also be present in the cytoplasm of certain cancer types.
Protocole
Product Specific Protocols | |
---|---|
IF protocol for CL555 c-MYC antibody CL555-10828 | Download protocol |
FC protocol for CL555 c-MYC antibody CL555-10828 | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |